Africa HIV Vaccine Trial Fails

3 September 2021

Lagos — An HIV vaccine candidate trialed in Sub-Saharan Africa offers no substantial protection against HIV infection among young women, the study organisers say.

According to a statement released this week (31 August) by Johnson & Johnson (J&J), the US drugmaker that produced the HIV vaccine candidate, the mid-stage Imbokodo study began in 2017, reached full enrollment in 2019 and completed vaccinations on 30 June 2020.

...

Tagged:

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.